Physician profile
William Curtis Eward
NPI 1164689006
$30,842.03
in general payments reported to CMS, 2019-2025
13 companies · $8,590 in 2025
The $8,590 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $125 · 2021: $125 · 2022: $683 · 2023: $4,671 · 2024: $2,669 · 2025: $8,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Education: $3,100 · Travel and Lodging: $917 · Food and Beverage: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,048.98 |
| Education | $3,100.00 |
| Travel and Lodging | $917.01 |
| Food and Beverage | $864.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Restor3d, INC. | $11,773.00 | 2021-2025 | |
| Daiichi Sankyo INC. | $11,112.25 | 2019 | |
| Carbofix Orthopedics INC | $3,396.00 | 2021-2025 | Tibia Nail |
| Musculoskeletal Transplant Foundation INC. | $1,534.70 | 2019 | |
| Bioventus LLC | $1,312.50 | 2019 | |
| Osteocentric Technologies, INC. | $980.04 | 2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Zimmer Biomet Holdings, INC. | $189.53 | 2023-2024 | Trabecular Metal, Allos Bone Substitues, Tapestry |
| Smith+Nephew, INC. | $180.17 | 2020-2025 | Evos, Trigen, Evos Mini |
| Onkos Surgical, INC. | $152.69 | 2019-2023 | Eleos Limb Salvage System |
| Illuminoss Medical, INC. | $139.29 | 2023-2025 | Photodynamic Bone Stabilization Procedure Pack |
| Linkbio Corp | $51.05 | 2022 | |
| Medtronic, INC. | $20.81 | 2024 | Osteocool Rf Ablation System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$497.96 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Eward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.